A quarterly subscription for NRIs managing Type 2 diabetes or metabolic health. CGM data analysis, GLP-1 medication stewardship, and remission-focused protocols — by an MRCP UK-certified diabetologist who understands both the South Asian metabolic phenotype and Western drug landscapes.
💬 Join the Metabolic Health DeskConsultant Physician & Diabetologist · Nirvana Clinic & Fortis Hospital, Delhi NCR
South Asians are genetically predisposed to insulin resistance and Type 2 diabetes — yet most NRIs receive fragmented, reactive care that manages blood sugar without ever targeting remission.
Endocrinologists in the US, UK, and UAE often have 3–6 month waiting lists. Your quarterly HbA1c check becomes a biannual event. Metabolic momentum is lost.
A quarterly HbA1c gives you a 3-month average — it misses the daily spikes, nocturnal lows, and post-meal surges that drive complications. You need CGM-level granularity.
Western endocrinologists often apply generic diabetes protocols. South Asians develop insulin resistance at lower BMIs and respond differently to medications. This nuance matters.
Ozempic and Mounjaro are transformative — but many NRIs are on them without structured monitoring. Dose titration, side effect management, and remission criteria need specialist oversight.
Modern diabetology has moved from reactive blood-sugar management to proactive metabolic control using Continuous Glucose Monitoring. Dr. Manuj analyses your CGM data to see what your HbA1c hides.
Time in Range, glycemic variability, nocturnal patterns, post-meal spikes, dawn phenomenon — these metrics tell the real story of your metabolic health. One CGM review often achieves more dietary change than six months of counselling.
Every quarter, you get a comprehensive metabolic review — not a 10-minute appointment, but a deep-dive into your data by a specialist who knows your history.
Upload your FreeStyle Libre, Dexcom, or Guardian data. Dr. Manuj analyses Time in Range, glycemic variability, nocturnal patterns, and post-meal responses.
Your HbA1c plotted over quarters — not just the number, but the trend, the rate of change, and what it means for your remission timeline.
Review of all diabetes medications — metformin, sulfonylureas, SGLT2 inhibitors, insulin — for dosing, timing, interactions, and whether they are still necessary.
If you are on Ozempic, Mounjaro, or Rybelsus: structured dose titration, side effect management, and remission criteria assessment. If you are not: whether you should be.
30–45 minute video call with Dr. Manuj. Timezone-friendly scheduling. Discussion of results, treatment adjustments, and goals for the next quarter.
Questions about a new food spike? Side effect concern? Message Dr. Manuj's clinic between quarterly reviews. No waiting for the next appointment.
A detailed metabolic review document you can share with your local doctor. Includes CGM interpretation, medication recommendations, and risk stratification.
Not just management — a structured path toward diabetes remission where clinically possible. Clear milestones, lifestyle targets, and medication tapering criteria.
One subscription. Continuous metabolic oversight. Cancel or pause anytime.
Quarterly subscription · By Dr. Manuj Sondhi, MRCP UK
Dr. Manuj has deep expertise in all three major GLP-1 agonists — understanding availability, cost, and naming differences across the USA, UK, UAE, and Australia.
Weekly injection. Gold standard for T2DM with weight loss benefit. Dose titration critical to minimise GI side effects.
Dual GIP/GLP-1 agonist. Superior A1c reduction in trials. Newer agent requiring careful titration and monitoring.
Oral GLP-1 for needle-averse patients. Requires strict fasting protocol. Absorption-sensitive — timing guidance is essential.
Weekly injection with simpler dosing. Good option when semaglutide is unavailable or cost-prohibitive in your country.
The Metabolic Health Desk is designed for NRIs who want more than reactive diabetes management — they want a path to remission.
You wear a FreeStyle Libre or Dexcom but your local GP doesn't do deep CGM interpretation. You want a specialist who reads the patterns, not just the average.
You're on Ozempic or Mounjaro but without structured monitoring. Nobody is tracking whether you're actually heading toward remission or just managing.
Your HbA1c has been hovering at 7–8% for years despite treatment. Something is being missed — and a fresh set of MRCP UK-trained eyes can find it.
You want a diabetologist who understands that South Asians develop insulin resistance at lower BMIs and respond differently to Western-standard protocols.
Your endocrinologist appointment is 4 months away. You want a detailed metabolic review within days, not quarters.
You've been told "diabetes is for life." You want a second opinion from a specialist who has helped patients achieve measurable remission.
From first message to your first quarterly review — simple, fast, and fully remote.
Tell us about your diabetes history, current medications, and what you want to achieve.
Upload recent HbA1c, CGM reports (if available), and current prescriptions.
Confirm your subscription. Pay securely in USD, GBP, AED, or INR.
Dr. Manuj conducts your CGM deep-dive and video consultation within 7 days.
Quarterly reviews. Between-visit WhatsApp access. Remission roadmap updated each quarter.
Medical Disclaimer: The Metabolic Health Desk is an advisory consultation and metabolic review service. It does not constitute primary care or replace face-to-face evaluation by a locally licensed physician. Medication recommendations are advisory — final prescribing authority rests with your local doctor. Diabetes remission outcomes vary by individual and are not guaranteed. CGM data interpretation is based on patient-uploaded data and assumes data accuracy. For medical emergencies, contact your local emergency services immediately.